Skip to main content

Table 1 Expression level of CELF1 in lung carcinoma and relationship to clinicopathological parameters

From: Si-RNA mediated knockdown of CELF1 gene suppressed the proliferation of human lung cancer cells

Variable Case no. CELF1 expression (RQ: 2-ΔΔCT) P value
Median Mean ± SEM
Gender
  Male 41 1.1090 1.2458 ± 0.9115 0.183
  Female 12 0.7252 0.8938 ± 103.53
Age
  ≤ 60.5 32 0.9000 1.0103 ± 0.8746 0.118
  > 60.5 21 0.1164 1.4035 ± 1.4948
Venous invasion
  Negative 40 1.0274 1.2302 ± 1.2217 0.251
  Positive 13 0.5492 0.9687 ± 0.9781
T stage
  T1 7 1.5105 1.396 ± 1.1033 0.041
  T2 21 1.2776 1.5178 ± 1.2898
  T3 17 0.6242 0.8040 ± 0.7079
  T4 8 0.3816 0.8109 ± 1.4910
N stage
  N0 25 0.6242 0.9983 ± 1.1184 0.251
  N1 11 1.3165 1.4731 ± 1.4334
  N2 17 1.1164 1.2142 ± 1.0611
Lymph node status
  N0 25 0.6242 0.9983 ± 1.1184 0.164
  N1 + N2 28 1.2321 1.3159 ± 1.2020
TNM stage
  Ia 4 1.2109 1.4055 ± 1.3481 0.089
  Ib 6 1.2500 1.4397 ± 0.9834
  IIa 5 1.3322 2.1861 ± 1.7131
  IIb 13 0.6242 0.7331 ± 0.5595
  IIIa 23 0.6624 1.1535 ± 1.2526
  IIIb 2 0.2747 0.2747 ± 0.3882
Differentiation
  Well 6 1.0545 0.8122 ± 0.5568 0.256
  Moderate 28 0.9000 1.1866 ± 1.1315
  Poor 19 1.0548 1.2476 ± 1.3613
Compared case
  Tumor tissue 10 1.5263 1.9005 ± 1.4382 0.012
  Normal tissue 10 0.2509 0.4579 ± 0.4761